Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- From humoral theory to performant risk stratification in kidney transplantation.J Immunol Res. 2017; 2017: 5201098
- Clinical and immunological relevance of antibodies in solid organ transplantation.Int J Immunogenet. 2016; 43: 351-368
- Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.J Clin Invest. 2017; 127: 2492-2504
- Lymphocyte crossmatching by flow cytometry.Methods Mol Biol. 2013; 1034: 285-296
- Clinical cytometry and progress in HLA antibody detection.Methods Cell Biol. 2011; 103: 285-310
- The lymphocyte crossmatch by flow cytometry for kidney transplantation.Methods Mol Biol. 2012; 882: 379-390
- The clinical importance of flow cytometry crossmatch in the context of CDC crossmatch results.Transplant Proc. 2010; 42: 3471-3474
- Significance of the positive crossmatch test in kidney transplantation.N Engl J Med. 1969; 280: 735-739
- Lymphocyte-dependent antibody and renal graft rejection.Lancet. 1975; 1: 953-954
- Microassays in transplantation immunology.Am J Med Technol. 1971; 37: 470-472
- Presensitization to transplants detected by cellular immunity tests.Transplantation. 1971; 12: 514-518
- Microdroplet assay of human serum cytotoxins.Nature. 1964; 204: 998-1000
- Mechanisms of immunologic enhancement.Transpl Proc. 1970; 2: 68-75
- HLA alloantibodies and the mechanism of the antiglobulin-augmented lymphocytotoxicity procedure.Hum Immunol. 1997; 56: 94-105
- Improved renal allograft survival for AHG and DTE/AHG crossmatch-negative recipients.Transpl Proc. 1991; 23: 400-402
- Detection of alloantibodies using a sensitive antiglobulin microcytotoxicity test: identification of low levels of pre-formed antibodies in accelerated allograft rejection.Tissue Antigens. 1972; 2: 215-226
- AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survival.Transplantation. 1991; 51: 316-320
- The role of crossmatching in organ transplantation.Arch Pathol Lab Med. 1991; 115: 255-259
- Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.Exp Mol Pathol. 2008; 85: 59-63
- Multilaboratory evaluation of serum analysis for HLA antibody and crossmatch reactivity by lymphocytotoxicity methods.Arch Pathol Lab Med. 2003; 127: 149-156
- A comparison of the antiglobulin versus extended incubation time crossmatch: results in 223 renal transplants.Transplant Proc. 1977; 9: 1803-1806
- Flow cytometry analysis: a high technology crossmatch technique facilitating transplantation.Transplant Proc. 1983; 15: 1939-1944
- Flow cytometry crossmatching for solid organ transplantation.Methods Cell Biol. 1994; 41: 103-119
- The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities.Transplantation. 1989; 48: 834-840
- Multicenter evaluation of the flow cytometry T-cell crossmatch: results from the American Society of Histocompatibility and Immunogenetics-College of American Pathologists proficiency testing program.Transplantation. 1997; 63: 1440-1445
- The relationship between flow cytometer crossmatch results and subsequent rejection episodes in cadaver renal allograft recipients.Transplantation. 1988; 45: 562-565
- The flow cytometric crossmatch and early renal transplant loss.Transplantation. 1990; 49: 527-535
- The relevance of a more sensitive crossmatch assay to renal transplantation.Transplantation. 1989; 47: 552-555
- Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch.J Am Soc Nephrol. 2001; 12: 2807-2814
- Flow cytometry in the transplant laboratory.Ann N Y Acad Sci. 1993; 677: 138-151
- Flow cytometry in human leukocyte antigen testing.Semin Hematol. 2001; 38: 194-200
- Flow cytometric assessment of HLA alloantibodies.Curr Protoc Cytom. 2004; Chapter 6 (Unit 6. 16)
- Pronase treatment facilitates alloantibody flow cytometric and cytotoxic crossmatching in the presence of rituximab.Hum Immunol. 2004; 65: 803-809
- False positive B-cells crossmatch after prior rituximab exposure of the kidney donor.Case Rep Transplant. 2016; 2016: 4534898
- Unexpected positive prospective crossmatches in organ transplant.Exp Clin Transplant. 2017; 15: 253-259
- Flow cytometry crossmatch reactivity with pronase-treated T cells induced by non-HLA autoantibodies in human immunodeficiency virus-infected patients.Hum Immunol. 2016; 77: 449-455
- Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells.J Immunol. 2015; 194: 3594-3600
- Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.Blood. 2011; 118: 5957-5964
- B peripheral lymphocytes express more HLA antigens than T peripheral lymphocytes.Transplantation. 1978; 25: 93-95
- Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity.eLife. 2018; 7: e34961
- HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.Blood. 2014; 124: 3996-4003
- The positive virtual crossmatch. Correlation between HLA DSA and flow cytometry crossmatch results.Hum Immunol. 2016; 77: 6
- Regulation of HLA class I and class II antigen expression.Br Med Bull. 1987; 43: 66-80
- Genetic predetermination of quantitative expression of HLA antigens in platelets and mononuclear leukocytes.Hum Immunol. 1993; 38: 243-250
- Pervasive haplotypic variation in the spliceo-transcriptome of the human major histocompatibility complex.Genome Res. 2011; 21: 1042-1054
- Previously believed to be nonsensical crossmatch results, explained by anti-HLA-C antibodies.Hum Immunol. 2017; 78: 75
- Variable expression of HLA-C impacts T versus B cell crossmatch outcomes.Hum Immunol. 2016; 77: 2
- Variable HLA expression on deceased donor lymphocytes: not all crossmatches are created equal.Hum Immunol. 2015; 76: 795-800
- Recombinant interferon-gamma increases HLA-DR synthesis and expression.J Immunol. 1983; 130: 1492-1494
- Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains.Hum Immunol. 2005; 66: 653-665
- Modification of HLA expression on peripheral lymphocytes and monocytes during aging.Mech Ageing Dev. 1998; 105: 209-220
- HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus.Clin Exp Immunol. 2001; 125: 485-491
- Rapid optimized flow cytometric crossmatch (FCXM) assays: the halifax and halifaster protocols.Hum Immunol. 2018; 79: 28-38
- Optimized flow cytometry crossmatch with increased sensitivity and specificity.Am J Transplant. 2016; 16: 609
- The use of pronase-digested human leukocytes to improve specificity of the flow cytometric crossmatch.Transpl Int. 1995; 8: 472-480
- Improved flow cytometric detection of HLA alloantibodies using pronase: potential implications in renal transplantation.Transplantation. 2001; 71: 422-428
- Impact of pronase on flow cytometric crossmatch outcome.Hum Immunol. 2011; 72: 330-336
- Frequent false-positive reactions in pronase-treated T-cell flow cytometric cross-match tests.Transplant Proc. 2012; 44: 87-90
- A comparative study of immunohistochemical methods for detecting abnormal prion protein with monoclonal and polyclonal antibodies.J Comp Pathol. 2000; 122: 43-53
- Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources.ILAR J. 2005; 46: 258-268
- Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients.Transplantation. 1990; 49: 52-56
Article info
Publication history
Published online: October 05, 2018
Footnotes
Disclosure Statement: This study was supported, in part, by a grant from the Mayo Clinic (A.J).
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.
